Company intelligence / Profile preview
HopeMed
Shanghai, Shanghai, China
- Ownership
- Private
- Employees
- ~80
- Development stage
- Other
01
Overview
HopeMed is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for endocrine, cardiovascular, and women's health diseases. The company's lead asset, HMI-115, is a first-in-class monoclonal antibody targeting the prolactin receptor, which was licensed from Bayer for global development and commercialization. HopeMed is currently advancing HMI-115 through multiple Phase 2 clinical trials for indications such as endometriosis and androgenetic alopecia. Founded by Professor Rui-Ping Xiao of Peking University, the company bridges high-quality academic research with global drug development expertise to address significant unmet medical needs.
- Therapeutic areas
- NephrologyWomen's HealthCardiovascularEndocrinologyDermatology
- Modalities
- Monoclonal antibodySmall molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Bayer
Beyond the preview
Go deeper on HopeMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HopeMed.